CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 119 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303,021 | +65.0% | 10,189 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $183,606 | +45.3% | 10,189 | +29.5% | 0.00% | 0.0% |
| Q1 2023 | $126,360 | -4.6% | 7,868 | +8.7% | 0.00% | 0.0% |
| Q4 2022 | $132,510 | -8.6% | 7,241 | -2.2% | 0.00% | 0.0% |
| Q3 2022 | $145,000 | +5.1% | 7,405 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $138,000 | -15.9% | 7,405 | -1.2% | 0.00% | 0.0% |
| Q1 2022 | $164,000 | -9.4% | 7,493 | +17.4% | 0.00% | 0.0% |
| Q4 2021 | $181,000 | – | 6,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 1,862,286 | $27,376,000 | 8.48% |
| Vivo Capital, LLC | 3,320,801 | $48,816,000 | 4.42% |
| Burrage Capital Management LLC | 282,272 | $4,022,000 | 3.96% |
| Opaleye Management Inc. | 368,750 | $5,421,000 | 1.44% |
| Perceptive Advisors | 2,587,953 | $38,042,000 | 0.99% |
| RA Capital Management | 1,961,209 | $28,830,000 | 0.91% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,073,000 | 0.62% |
| EcoR1 Capital, LLC | 350,000 | $5,145,000 | 0.54% |
| Orbimed Advisors | 2,039,282 | $29,977,000 | 0.50% |
| Eventide Asset Management | 947,000 | $13,921,000 | 0.45% |